INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Quarterly Results

Change Company Name

Zydus Lifesciences Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 532321	ISIN Demat INE010B01027	Book Value 210.59	NSE Symbol ZYDUSLIFE	Dividend Yield (%) 1.13	Market Cap (₹ Cr.) 98,107.81	P/E 16.99	EPS 57.39	Face Value 1

Particulars (₹ Cr)	Mar 2025	Dec 2024	Sep 2024	Jun 2024

Gross Sales/Income from operations	5633.5	2408.9	2512.3	4035.4
Less: Excise duty	0.00	0.00	0.00	0.00
Net Sales/Income from operations	5,633.50	2,408.90	2,512.30	4,035.40
Other Operating Income	186.10	107.00	108.30	124.80
Total Income from operations (net)	5,819.60	2,515.90	2,620.60	4,160.20
Total Expenses	2,174.90	1,999.00	1,812.10	1,917.90
Cost of Sales	690.20	935.70	653.00	738.00
Employee Cost	476.30	425.00	436.50	424.40
Depreciation, amortization and depletion expense	128.00	131.60	133.70	130.60
Provisions & Write Offs	0.00	0.00	0.00	0.00
Administrative and Selling Expenses	0.00	0.00	0.00	0.00
Other Expenses	880.40	506.70	588.90	624.90
Pre Operation Expenses Capitalised	0.00	0.00	0.00	0.00
Profit from operations before other income, finance costs and exceptional items	3,644.70	516.90	808.50	2,242.30
Other Income	185.40	77.50	326.70	106.60
Profit from ordinary activities before finance costs and exceptional items	3,830.10	594.40	1,135.20	2,348.90
Finance Costs	155.40	97.20	95.90	115.40
Profit from ordinary activities after finance costs but before exceptional items	3,674.70	497.20	1,039.30	2,233.50
Exceptional Items	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00
Profit from ordinary activities before tax	3,674.70	497.20	1,039.30	2,233.50
Total Tax	861.00	26.60	249.50	532.70
Net profit from Ordinary Activities After Tax	2,813.70	470.60	789.80	1,700.80
Profit / (Loss) from Discontinued Operations	0.00	0.00	0.00	0.00
Net profit from Ordinary Activities/Discontinued Operations After Tax	2,813.70	470.60	789.80	1,700.80
Extraordinary items	0.00	0.00	0.00	0.00
Other Adjustments After Tax	0.00	0.00	0.00	0.00
Net Profit after tax for the Period	2,813.70	470.60	789.80	1,700.80
Other Comprehensive Income	11.20	-3.20	-10.70	9.10
Total Comprehensive Income	2,824.90	467.40	779.10	1,709.90
Equity	100.60	100.60	100.60	100.60
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00
EPS:
EPS before Exceptional/Extraordinary items-Basic	27.96	4.68	7.85	16.90
EPS before Exceptional/Extraordinary items-Diluted	27.96	4.68	7.85	16.90
EPS after Exceptional/Extraordinary items-Basic	27.96	4.68	7.85	16.90
EPS after Exceptional/Extraordinary items-Diluted	27.96	4.68	7.85	16.90
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend Per Share(Rs.)	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00
No. of Employees	0.00	0.00	0.00	0.00
Debt Equity Ratio	0.00	0.00	0.00	0.00
Debt Service Coverage Ratio	0.00	0.00	0.00	0.00
Interest Service Coverage Ratio	0.00	0.00	0.00	0.00
Debenture Redemption Reserve (Rs cr)	0.00	0.00	0.00	0.00
Paid up Debt Capital (Rs cr)	0.00	0.00	0.00	0.00